Newborn screening for lysosomal storage disorders.

Area of Science:

• Biochemistry
• Genetics
• Pediatrics

Background:

• Lysosomes are vital organelles for cellular waste degradation.
• Lysosomal storage disorders (LSDs) arise from enzyme deficiencies, leading to material accumulation and disease.
• Therapeutic interventions exist for several LSDs, improving prognosis if initiated early.

Purpose of the Study:

• To review newborn screening strategies for LSDs.
• To discuss the advantages and limitations of these screening approaches.
• To highlight LSDs suitable for newborn screening due to available therapies.

Main Methods:

• Review of existing literature on LSDs and newborn screening.
• Analysis of therapeutic options including enzyme replacement and bone marrow transplantation.
• Evaluation of pilot newborn screening projects for specific LSDs.

Main Results:

• Several LSDs, including Gaucher, Fabry, and Pompe diseases, are candidates for newborn screening.
• Pilot studies demonstrate the feasibility of implementing newborn screening for certain LSDs.
• Early intervention is crucial for preventing irreversible organ damage and improving long-term outcomes.

Conclusions:

• Newborn screening for LSDs is a viable strategy to improve patient health outcomes.
• The selection of LSDs for screening should be based on therapeutic availability and screening method suitability.
• Further research and implementation of screening programs are warranted for effective LSD management.